Josie Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.1/10
Best for: women in perimenopause or menopause who want GLP-1s and hormone therapy from one telehealth brand
Josie falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $189 a month; its compounded semaglutide, at $249, is 25% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
microdose tier; standard plans start at $194/mo
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked November 2026
Josie is a telehealth brand for women in perimenopause and menopause that sells compounded semaglutide and tirzepatide as injections, dissolving tablets and microdoses, brand Wegovy, Ozempic and Zepbound, and compounded hormone therapy. Compounded injections are $249 a month for semaglutide and $349 for tirzepatide at any dose, less on 3, 6 or 12-month plans paid up front. Microdoses are $189 a month. The FDA sent Josie a warning letter in February 2026.
Is Josie legit?
Josie is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate Josie 6.1/10 overall.
Is there a Josie promo or coupon code?
We know of no promo or coupon code for Josie. Its listed price is $189 a month. Coupon sites advertising "Josie discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Josie compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Josie
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Josie at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Zepbound
- Starting price
- $189/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication
- FDA status
- 1 FDA warning letter (details below)
How Josie scores
Six columns, each one computed from something Josie has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.4/10$249/month is 25% above the $199 median for compounded semaglutide across the sellers we compare. A cheaper plan paid several months up front is also listed. A cheaper microdose price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
3.5/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Josie
Last checked November 2026- Checked the listed price across 11 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Josie
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Josie involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Josie shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Josie which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication.
- Lowest ongoing monthly price: semaglutide $189, tirzepatide $189. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Josie serves your state before you start.
- The FDA has issued Josie a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Josie
- Josie offers email support
- Hours
- Email replies within one business day
Cancelling Josie
Taken from the terms Josie publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly, or 3, 6 or 12-month plans billed once up front
- Refund policy
- Not published by the seller
Medications Josie lists
Josie lists Wegovy, Ozempic, Zepbound, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Product page: "$249/mo", "Billed monthly", "Same price at any dose".
12 mo tab: "$194/mo", "$2,327 billed once · 12-month plan". Also 3 months $699 ($233/mo) and 6 months $1,194 ($199/mo), each billed once.
Product page: "$349/mo", "Billed monthly", "Same price at any dose".
12 mo tab: "$233/mo", "$2,799 billed once · 12-month plan". Also 3 months $799 ($266/mo) and 6 months $1,499 ($250/mo).
"Compounded Oral Semaglutide ODT" "$299/mo" billed monthly; 3 months $799 ($266/mo), 6 months $1,434 ($239/mo), 12 months $2,717 ($226/mo), each billed once.
"Compounded Oral Tirzepatide ODT" "$349/mo" billed monthly; 3 months $899 ($300/mo), 6 months $1,599 ($267/mo), 12 months $2,899 ($242/mo), each billed once.
"Microdose Semaglutide" "$189/mo", "Month-to-month plan." The cart also lists a Microdose Semaglutide ODT at $189. Site: "Microdosing is not an FDA-approved dosing regimen."
"Microdose Tirzepatide" "$189/mo", "Month-to-month plan." The cart also lists a Microdose Tirzepatide ODT at $189.
Wegovy page: "$1,199/mo", "Includes your provider consult and the medication, shipped to you."
Ozempic page: "$1,299/mo", "Includes your provider consult and the medication, shipped to you." Ozempic is FDA-approved for type 2 diabetes, not weight loss.
Zepbound page: "$1,099/mo", "Includes your provider consult and the medication, shipped to you."
Check the price yourself before you pay
Every figure here comes from Josie's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication
Against it
- Semaglutide costs $249 a month, 25% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 30% above the $269 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Josie a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Josie charges
Josie charges $189/month for its microdose tier; its standard plans start at $194/month and hold that rate across every dose.
- Compounded semaglutide (injection, monthly): $249/month
- Compounded semaglutide (injection, 12-month plan): $194/month
- Compounded tirzepatide (injection, monthly): $349/month
- Compounded tirzepatide (injection, 12-month plan): $233/month
- Compounded semaglutide (tablet, monthly): $299/month
- Compounded semaglutide (microdose injection, monthly): $189/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Josie's $249 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Some of Josie's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What Josie dispenses
Josie prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. Josie also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Josie at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Josie tells you its price before you start the medical questionnaire. The FDA has issued Josie a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Josie will not tell you, treat that as a warning sign. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You need insurance to cover the cost. Check whether Josie bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- you want the price to stop moving as your dose climbs
- injections are the thing keeping you from starting
Our read
Josie costs more than the middle of this market, and the oral option is the clearest thing that premium buys. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why Josie scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Belle Health is the nearest comparison we review, and worth reading alongside this. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
Josie falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $189 a month; its compounded semaglutide, at $249, is 25% above the $199 median among the sellers we compare.
Before you pay Josie
Starting at $189 a month. Check today's price, then start the intake.
Where Josie is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Josie sets more sellers in the same category beside Josie on price, states and what the price includes.
Frequently Asked Questions
How to check Josie yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Josie has an FDA warning letter on record, dated February 20, 2026
This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this Josie review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Josie's current pricing
Plans start at $189 a month. Whether you qualify is a clinician's decision, made after your intake.